http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63119424-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
filingDate 1987-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04dbdb20c6db7d9059d8a9ac61665151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d330e4c2b632817f4bc3b3965f74c981
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99e6f05d029e828b6eb462ba35404174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06b6f0060721bdf16f70a35aec2a3f11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_331c8328c5f7f7856171fd4515288ca3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd328c85bb3af48dd6b584a7b7dab0e
publicationDate 1988-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S63119424-A
titleOfInvention Muscle relaxant
abstract PURPOSE: To obtain a muscle relaxant containing an aminoketone derivative or a salt thereof as an active ingredient. n CONSTITUTION: A muscle relaxant obtaining a compound shown by formula I (R 1 is p-trihalogenomethyl) or a salt thereof as an active ingredient. The compound shown by formula I as the active ingredient is obtained by reacting 1 equivalent compound shown by formula II with ≥0.5 equivalent, preferably 1W10 equivalents formaldehyde and pyrrolidine. The reaction is carried out in the presence of preferably a catalytic amount of an acid, more preferably hydrochloric acid in the absence of a solvent or preferably in a solvent (e.g. alcohol such as propanol, isopropanol, butanol, etc., ketone such as acetone, etc.) at 0W200°C, preferably 10°CW about boiling point of the solvent for 0.5W4hr, preferably 3W48hr. The relaxant may be orally or parenterally administered. A dose is 0.1W20mg/kg/day. The agent has prolonged effects, relaxing action on rigidity in a decerebrate specimen and further anticonvulsant action. n COPYRIGHT: (C)1988,JPO&Japio
priorityDate 1985-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701

Total number of triples: 44.